Edward L. Schwartz

7.6k total citations · 2 hit papers
121 papers, 5.9k citations indexed

About

Edward L. Schwartz is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Edward L. Schwartz has authored 121 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Biology, 47 papers in Oncology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Edward L. Schwartz's work include Colorectal Cancer Treatments and Studies (15 papers), Cancer Treatment and Pharmacology (13 papers) and Cancer-related Molecular Pathways (11 papers). Edward L. Schwartz is often cited by papers focused on Colorectal Cancer Treatments and Studies (15 papers), Cancer Treatment and Pharmacology (13 papers) and Cancer-related Molecular Pathways (11 papers). Edward L. Schwartz collaborates with scholars based in United States, Germany and China. Edward L. Schwartz's co-authors include Scott Wadler, Bärbel Friedrich, Peter H. Wiernik, Janice P. Dutcher, Richard B. Lipton, J Strauman, Alan C. Sartorelli, Kylie A. Hotchkiss, Anthony W. Ashton and Elisabeth Paietta and has published in prestigious journals such as Physical Review Letters, JAMA and Nucleic Acids Research.

In The Last Decade

Edward L. Schwartz

117 papers receiving 5.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genome sequence of the bioplastic-producing “Knallgas” bacterium Ralstonia eutropha H16

2006 503 citations Anne Pohlmann, Edward L. Schwartz et al. profile →
Phase I clinical and pharmacokinetic study of taxol.

1987 380 citations Edward L. Schwartz, J Strauman et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edward L. Schwartz United States	38	2.6k	2.3k	650	575	550	121	5.9k
Takahiro Yano United States	44	3.0k 1.1×	947 0.4×	222 0.3×	511 0.9×	160 0.3×	121	5.4k
Héctor M. Álvarez Argentina	37	3.6k 1.4×	1.1k 0.5×	932 1.4×	187 0.3×	253 0.5×	97	5.5k
David Stirling United Kingdom	47	5.3k 2.0×	2.7k 1.2×	313 0.5×	164 0.3×	297 0.5×	109	10.1k
Na Huang China	37	2.1k 0.8×	822 0.4×	1.2k 1.9×	160 0.3×	722 1.3×	132	4.7k
Toru Beppu Japan	55	6.4k 2.4×	3.0k 1.3×	1.3k 2.0×	95 0.2×	1.1k 2.0×	418	12.6k
Jason L. Johnson United Kingdom	46	2.5k 0.9×	697 0.3×	1.7k 2.7×	604 1.1×	882 1.6×	163	7.5k
Pierre Richaud France	48	2.3k 0.9×	722 0.3×	208 0.3×	1.3k 2.2×	1.7k 3.1×	230	8.4k
Hisashi Tanaka Japan	41	2.2k 0.8×	802 0.3×	538 0.8×	267 0.5×	221 0.4×	224	4.6k
Shuhang Wang China	37	1.2k 0.4×	1.8k 0.8×	718 1.1×	86 0.1×	1.3k 2.4×	216	4.4k
Deborah B. Zamble Canada	35	1.9k 0.7×	801 0.3×	174 0.3×	630 1.1×	139 0.3×	74	3.7k

Countries citing papers authored by Edward L. Schwartz

Since Specialization

Citations

This map shows the geographic impact of Edward L. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward L. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward L. Schwartz more than expected).

Fields of papers citing papers by Edward L. Schwartz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward L. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward L. Schwartz. The network helps show where Edward L. Schwartz may publish in the future.

Co-authorship network of co-authors of Edward L. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Edward L. Schwartz. A scholar is included among the top collaborators of Edward L. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward L. Schwartz. Edward L. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Jichuan, Edward L. Schwartz, Maja H. Oktay, et al.. (2023). SKP2 Knockout in Rb1/p53–Deficient Mouse Models of Osteosarcoma Induces Immune Infiltration and Drives a Transcriptional Program with a Favorable Prognosis. Molecular Cancer Therapeutics. 23(2). 223–234. 12 indexed citations

Zhao, Hongling, et al.. (2020). Targeted Inhibition of the E3 Ligase SCFSkp2/Cks1 Has Antitumor Activity in RB1 -Deficient Human and Mouse Small-Cell Lung Cancer. Cancer Research. 80(11). 2355–2367. 28 indexed citations

Zou, Yiyu, Yi‐He Ling, Juan Sironi, et al.. (2013). The Autophagy Inhibitor Chloroquine Overcomes the Innate Resistance of Wild-Type EGFR Non-Small-Cell Lung Cancer Cells to Erlotinib. Journal of Thoracic Oncology. 8(6). 693–702. 104 indexed citations

Lu, Haiyan, Robert S. Klein, & Edward L. Schwartz. (2009). Antiangiogenic and Antitumor Activity of 6-(2-Aminoethyl)Amino-5-Chlorouracil, a Novel Small-Molecule Inhibitor of Thymidine Phosphorylase, in Combination with the Vascular Endothelial Growth Factor-Trap. Clinical Cancer Research. 15(16). 5136–5144. 21 indexed citations

Schwartz, Edward L., Birgit Voigt, Daniela Zühlke, et al.. (2009). A proteomic view of the facultatively chemolithoautotrophic lifestyle of Ralstonia eutropha H16. PROTEOMICS. 9(22). 5132–5142. 66 indexed citations

Lu, Haiyan, Janice Murtagh, & Edward L. Schwartz. (2006). The Microtubule Binding Drug Laulimalide Inhibits Vascular Endothelial Growth Factor-Induced Human Endothelial Cell Migration and Is Synergistic when Combined with Docetaxel (Taxotere). Molecular Pharmacology. 69(4). 1207–1215. 51 indexed citations

Hotchkiss, Kylie A., Anthony W. Ashton, & Edward L. Schwartz. (2003). Thymidine Phosphorylase and 2-Deoxyribose Stimulate Human Endothelial Cell Migration by Specific Activation of the Integrins α5β1 and αVβ3. Journal of Biological Chemistry. 278(21). 19272–19279. 65 indexed citations

Hotchkiss, Kylie A., et al.. (2003). Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration.. PubMed. 63(2). 527–33. 96 indexed citations

Lenzi, Michelle L., et al.. (2002). The Sp1 transcription factor contributes to the tumor necrosis factor-induced expression of the angiogenic factor thymidine phosphorylase in human colon carcinoma cells. Oncogene. 21(55). 8477–8485. 61 indexed citations

10.

Schwartz, Edward L., et al.. (1997). Measurement of deoxyuridine triphosphate and thymidine triphosphate in the extracts of thymidylate synthase-inhibited cells using a modified DNA polymerase assay. Biochemical Pharmacology. 54(5). 635–638. 26 indexed citations

11.

Schwartz, Edward L., et al.. (1993). Dimethyl sulfoxide inhibits the binding of granulocyte/macrophage colony-stimulating factor and insulin to their receptors on human leukemia cells.. PubMed. 53(5). 1142–8. 2 indexed citations

12.

Fleischmajer, Raúl, et al.. (1992). Immunochemical analysis of human kidney reticulin.. PubMed Central. 140(5). 1225–35. 22 indexed citations

13.

Schwartz, Edward L., et al.. (1992). Nucleotide sequence of the rpoN (hno) gene region of Alcaligenes eutrophus: evidence for a conserved gene cluster. Archives of Microbiology. 158(2). 107–114. 36 indexed citations

14.

Wadler, Scott & Edward L. Schwartz. (1992). Principles in the biomodulation of cytotoxic drugs by interferons.. PubMed. 19(2 Suppl 3). 45–8. 13 indexed citations

15.

Gallagher, RE, et al.. (1989). Variable Regulation of Sensitivity to Retinoic Acid-induced Differentiation in Wild-type and Retinoic Acid-resistant HL-60 Cells. PubMed. 1(1). 45–54. 9 indexed citations

16.

Schwartz, Edward L., et al.. (1985). High performance liquid chromatographic analysis (HPLC) and human pharmacokinetics of taxol (NSC 125973). Proceedings of the American Association for Cancer Research. 26. 2 indexed citations

17.

Ishiguro, Kimiko, Edward L. Schwartz, P S Dannies, & Alan C. Sartorelli. (1982). Studies on the mechanism of 6-thioguanine-induced cellular differentiation using clonal resistant variants of HL60 human promyelocytic leukemia. Proceedings of the American Association for Cancer Research. 23. 2 indexed citations

18.

Schwartz, Edward L. & Jay I. Goodman. (1979). A comparison of procedures for fractionating hepatic chromatin. Journal of Pharmacological Methods. 2(2). 161–174. 4 indexed citations

19.

Schwartz, Edward L., et al.. (1977). Preliminary observations on cardiovascular effects of l-α-acetylmethadol (LAAM) in vivo. Federation Proceedings. 36(3).

20.

Schwartz, Edward L.. (1968). Isolated Dextrocardia with Right Ventricular Dominance. Diseases of the Chest. 54(3). 249–249. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact